These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7022385

  • 21. [Mucolytic therapy for respiratory system diseases. Clinical-experimental results before and after treatment with Transbronchin].
    Primer G.
    Ther Ggw; 1975 Aug; 114(8):1251-66. PubMed ID: 1108276
    [No Abstract] [Full Text] [Related]

  • 22. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
    Goodman RM, Yergin BM, Sackner MA.
    Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
    Braga PC, Borsa M, De Angelis L, Bossi R, Allegra L, Scaglione F, Scarpazza G.
    Clin Ther; 1982 Dec; 4(6):480-8. PubMed ID: 7093981
    [Abstract] [Full Text] [Related]

  • 27. [Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients].
    Cegla UH.
    Prax Klin Pneumol; 1988 Sep; 42(9):715-21. PubMed ID: 3141915
    [No Abstract] [Full Text] [Related]

  • 28. [The mucolytic effects of acetylcysteine compared with bromhexine and a placebo in patients with chronic bronchitis].
    Heinig JH, Pedersen B, Andersen I, Dalgaard CE, Rasmussen O, Weeke ER, Enk B.
    Ugeskr Laeger; 1985 Nov 11; 147(46):3694-7. PubMed ID: 3907080
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Guaimesal capsules in the treatment of exacerbated chronic bronchitis].
    Ghiringhelli G.
    Clin Ter; 1984 Sep 30; 110(6):533-9. PubMed ID: 6238767
    [No Abstract] [Full Text] [Related]

  • 32. Cephalexin in the prevention of purulent exacerbations of chronic bronchitis.
    Pines A.
    Br J Clin Pract; 1972 May 30; 26(5):209-10. PubMed ID: 4558073
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Functional and clinical evaluation of feprazonebromhexine association in bronchopulmonary diseases.
    Del Bono N, Quartieri F, Renda B, Sconosciuto F, Vibelli C.
    Panminerva Med; 1978 May 30; 20(2):117-22. PubMed ID: 360150
    [No Abstract] [Full Text] [Related]

  • 36. Life table analysis of long-term randomised trials in pneumology--a worked example and a plea.
    Ferrari V, Spinelli W.
    Eur J Respir Dis Suppl; 1980 May 30; 110():227-36. PubMed ID: 7011829
    [No Abstract] [Full Text] [Related]

  • 37. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
    Thomson ML, Pavia D, Jones CJ, McQuiston TA.
    Thorax; 1975 Dec 30; 30(6):669-73. PubMed ID: 769242
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Effect of the bronchospasmolytic agent Repreterol on the blood glucose level in diabetics].
    Tabori D, Conkić B, Aurich R.
    Med Welt; 1979 Apr 06; 30(14):531-4. PubMed ID: 372730
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.